Journal of
Diabetes and Endocrinology

  • Abbreviation: J. Diabetes Endocrinol.
  • Language: English
  • ISSN: 2141-2685
  • DOI: 10.5897/JDE
  • Start Year: 2010
  • Published Articles: 69

Full Length Research Paper

Factors contributing to glycaemic control in an urban population of adults living with type 2 diabetes in Cameroon: A community-based cross-sectional study

Loveline Lum Niba
  • Loveline Lum Niba
  • Department of Public Health, The University of Bamenda, P. O. Box 39, Bambili, Bamenda, Cameroon.
  • Google Scholar
Lifoter Kenneth Navti
  • Lifoter Kenneth Navti
  • Department of Biochemistry, University of Bamenda, P. O. Box 39, Bambili, Bamenda, Cameroon.
  • Google Scholar


  •  Accepted: 18 January 2023
  •  Published: 31 January 2024

References

Abdissa D, Hirpa D (2021). Poor glycaemic control and its associated factors among diabetes patients attending public hospitals in West Shewa Zone, Oromia, Ethiopia: An Institutional based cross-sectional study. Metabolism Open 13(2022):1-7.
Crossref

 

Abdullah NA, Ismail S, Ghazali SS, Juni MH, Shahar HK, Aziz NRA (2019). Predictors of Good Glycemic Controls Among Type 2 Diabetes Mellitus Patients in Two Primary Health Clinics, Kuala Selangor. Malaysian Journal of Medicines and Health Sciences 15(SP3): 58-64.

View

 

Afroz A, Ali L, Karim N, Alramadan MJ, Alam M, Maglino DJ, Billah B (2019). Glycaemic Control for people with Type 2 Diabetes Mellitus in Bangladesh - An urgent need for optimization of management plan. Scientific Reports 9(10248):1-10.
Crossref

 

Agidew E, Wale MZ, Kerebih H, Yirsaw MT, Zewdie TH, Girma M, Miskir A (2021). Adherence to diabetes self-care management and associated factors among people with diabetes in Gamo Gofa Zone public health hospitals. SAGE Open Medicine 9:1-7.
Crossref

 

Alzaheb RA, Altemani AH (2018). The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia, Diabetes. Metabolic Syndrome and Obesity: Targets and Therapy 11:15-21.
Crossref

 

American Diabetes Association (ADA) (2015). Standards of medical care in diabetes-2015: Position statement. Diabetes Care 38(Suppl 1):S1-S93.

 

American Diabetes Association (ADA) (2018) 'Standards of medical care in diabetes - 2018: Position statement'. Diabetes Care 41(Suppl 1): S13-S27.
Crossref

 

American Diabetes Association (ADA) (2022) Standards of medical care in diabetes-2022. Diabetes Care 45(Suppl.1):S1-S259.
Crossref

 

Amsah N, Isa ZM, Kassim Z (2022). Poor glycaemic control and its associated factors among type 2 diabetes mellitus patients in southern part of peninsular Malaysia: a Registry-based study Macedonian Journal of Medical Sciences 9(E):422-427.
Crossref

 

Anioke IC, Ezedigboh AN, Nwakile OCD, Chukwu IJ, Kalu PN (2019). Predictors of poor glycemic control in adult with type 2 diabetes in South-Eastern Nigeria. African Health Science 19(4):2819-2828.
Crossref

 

Arai K, Hirao K, Matsuba I, Takai M, Matoba K, Takeda H, Kanamori A, Yamauchi M, Mori H, Terauchi Y (2009). The status of glycaemic control by general practitioners and specialists for diabetes in Japan: a cross-sectional survey of 15,652 patients with diabetes mellitus. Diabetes. Research in Clinical Practice 83(3):397-401.
Crossref

 

Atc? MM, Pamukçu Cerciz Ö, Kayar Y, Borlu F, Altunta? Y (2022). The Relationship Between Poor Glycaemic Control and Risk Factors in Patients with Type 2 Diabetes Mellitus. Eurasian Journal of Medical Advances 2(2):46-54.
Crossref

 

Ayomote UA, Ogbonna AN, Akujuobi OM (2022). Glycemic control and its associated factors among elederly diabetic patients in a tertiary hospital in Lagos, Nigeria. Current Research in Diabetes and Obesity Journal 16(1):1-12.
Crossref

 

Azzam MM, Ibrahim AA, Abd El-Ghany MI (2021). Factors affecting glycemic control among Egyptian people with diabetes attending primary health care facilities in Mansoura District. Egyptian Journal of Critical Care Medicine 33(1):1-10
Crossref

 

Berkowitz SA, Meigs JB, Wexler DJ (2013). Age at type 2 diabetes onset and glycaemic control: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2010. Diabetologia.
Crossref

 

Beulens JWJ, Pinho MGM, Abreu TC, den Braver NR, Lam TM, Hus A, Vlaaanderen J, Sonnenschein T, Siddiqui NZ, Yuan Z, Kerckhoffs J, Zhernakova A, Gois MFB, Vermeulen RCH (2022). Environmental risk factors of type 2 diabetes - an exposome approach. Diabetologia 65(2):263-274.
Crossref

 

Bitew ZW, Alemu A, Jember DA, Tadesse E, Getaneh FB, Seid A, Weldeyonnes, M (2023). Prevalence of Glycemic Control and Factors Associated with Poor Glycemic Control: A Systematic Review and Meta-analysis. INQUIRY: The Journal of Health Care Organization, Provision, and Financing.
Crossref

 

Cai X, Xia L, Pan Y, Zhu H, Wei T, He Y (2019). Differential role of insulin resistance and β-cell function in the development of prediabetes and diabetes in middle-aged and elderly Chinese population. Diabetology and Metabolic Syndrome 11(24):1-8. 
Crossref

 

Chetoui A, Kaoutar K, Almoussaui S, Boutahr K, El Kardoudi A, Chigr F, Najimi M (2019). Prevalence and determinants of poor glycaemic control: a cross-sectional study among Moroccan type 2 diabetes patients. International Health 14(4):390-397.
Crossref

 

Chia CW, Egan JM, Ferrucci L (2018). Age-related changes in glucose metabolism, hyperglycaemia and cardiovascular risk. Circulation Research 123(7):886-904.
Crossref

 

Chiu C-J, Wray LA (2010). Factors predicting glycemic control in middle-aged and older adults with type 2 diabetes. Preventing Chronic Disease 7(1):1-11.

 

Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000). Establishing a standard definition for child overweight and obesity worldwide: international survey. British Medical Journal 320(7244):1240-1243.
Crossref

 

Degefa G, Wubshet K, Tesfaye S, Hirigo AT (2020). Predictors of adherence towards specific domains of diabetic self-care among type diabetes patients, Endocrinology and Diabetes 13:1-12.
Crossref

 

Demoz GT, Gebremariam A, Yifter H, Alebachew M, Niriayo YL, Gebreslassie G, Woldu G, Bahrey D, Shibeshi W (2019). Predictors of poor glycemic control among patients with type 2 diabetes on follow-up care at a tertiary healthcare setting in Ethiopia. BMC Research Notes 12(207):1-7.
Crossref

 

Dubale M, Gizaw K, Dessalegn D (2023). Magnitude and predictors of poor glycemic control in patients with diabetes at Jimma Medical Center, Ethiopia. Scientific Reports 13(15952):1-11.
Crossref

 

Enikuomehin AC, Olamoyegun MA, Ojo OA, Ajani GD, Akinlade TA, Ala OA (2021). Pattern of self-care practices among type 2 diabetes patients in Southwest, Nigeria. Niger Journal of Clinical Practice 24(7):978-985.
Crossref

 

Fiseha T, Alemayehu E, Kassahun W, Adamu A, Gebreweld A (2018). Factors associated with glycemic control among diabetic adult out-patients in Northeast Ethiopia. BMC Research Notes 11(1):1-6.
Crossref

 

Fowler MJ (2008). Microvascular and Macrovascular Complications of Diabetes. Clinical Diabetes 26(2):77-82.
Crossref

 

International Diabetes Federation (IDF) (2021). Diabetes Atlas, 10th edition. Brussels, Belgium: International Diabetes Federation.

 

Kassa RN, Inrahim, IY, Hailemariam, HA, Habte MH (2021). Self-care practice and its predictors among adults with diabetes mellitus on follow up at public hospitals of Arsi zone, southeast Ethiopia. BMC Research Notes 14(102):1-6.
Crossref

 

Kengne AP, Amoah AG, Mbanya JC (2005). Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation 112(23):3592-3601.
Crossref

 

Ketema EB, Kibret KT (2015). Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis. Archives of Public Health 73:43.
Crossref

 

Khattab M, Khader Y, Al-Khawaldeh A, Ajloun K (2010) Factors associated with poor glycaemic control among patients with type 2 diabetes. Journal of Diabetes and Complications 24(2):84-89.
Crossref

 

Legese GL, Asres G, Alemu S, Yesuf T, Tesfaye YA, Amare T (2023). Determinants of poor glycemic control among type 2 diabetes mellitus patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: Unmatched case-control study. Frontiers in Endocrinology 14(1087437):1-11.
Crossref

 

LeRoith D, Smith DO (2005). Monitoring glycemic control: the cornerstone of diabetes care. Clinical Therapy 27(10):1489-99.
Crossref

 

Mariye T, Bahrey D, Tasew H, Teklay G, Gebremichael BG, Teklu G, Mebrahtom G, Aberhe W (2020). Determinants of poor glycemic control among diabetes mellitus patients in public hospitals of the central zone, Tigray, North Ethiopia, 2018: Unmatched Case-Control Study. Endocrinology and Metabolism Open Access 4(1):1-7.
Crossref

 

Mobula LM, Sarfo FS, Carson KA, Burnham G, Arthur L, Ansong D, Sarfo-Kantanka O, Plange-Rhule J (2018). Predictors of glycaemic control in type 2 diabetes mellitus: Evidence from a multicentre study in Ghana, Translational Metabolic Syndrome Research 1(2018):1-8.
Crossref

 

Nanayakkara N, Ranasinha S, Gadowski AM, Davis WA, Flack JR, Wischer N, Andrikopoulos S, Zoungas S (2018). Age-related differences in glycaemic control, cardiovascular disease risk factors and treatment in patients with type 2 diabetes: a cross-sectional study from the Australian National Diabetes Audit. BMJ Open 8(8):e020677. 
Crossref

 

Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C (1993). The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 329(14):977-986.
Crossref

 

Omar S, Musa IR, Elsouli A, Adam I (2019). Prevalence, risk factors, and glycaemic control of type 2 diabetes mellitus in eastern Sudan: a community-based study. Therapeutic Advances in Endocrinology and Metabolism 10:1-8.
Crossref

 

Patrick NB, Yadesa TM, Muhindo R, Lutoti S (2021). Poor Glycemic Control and the Contributing Factors Among Type 2 Diabetes Mellitus Patients Attending Outpatient Diabetes Clinic at Mbarara Regional Referral Hospital, Uganda. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 14:3123-3130.
Crossref

 

Rakhis SAB, AlDuwayhis NM, Aleid N, AlBarrak AN, Aloraini AA (2022). Glycemic control for type 2 diabetes mellitus patients: A Systematic Rview. Cureus 14(6):e26180.

 

Reed J, Bain S, Kanamarlapudi V (2021). A review of current trends in type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives. Diabetes, Metabolic, Syndrome and Obesity: Targets and Therapy 4:3567-3602.
Crossref

 

Reisig V, Reitmeir P, Döring A, Rathmann W, Mielck A, KORA Study Group (2007). Social inequalities and outcomes in type 2 diabetes in the German region of Augsburg. A cross-sectional survey. International Journal of Public Health 52(3):158-165.
Crossref

 

Rewers M, Ludvigsson J (2016). Environmental risk factors for type 1diabetes. Lancet 387(10035):2340-2348.
Crossref

 

Schmitt A, Gahr A, Hermanns N, Kulzer B, Huber J, Haak T (2013). The Diabetes self?management questionnaire (DSMQ): Development and evaluation of an instrument to assess diabetes self?care activities associated with glycaemic control. Health Qual Life Outcomes 11(138):1-14.
Crossref

 

Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO (2008). Managing type 2 diabetes: going beyond glycaemic control. Journal of Managed Care Pharmacy 14(5):S19-S25.
Crossref

 

Stratton IM, Adler AI, Neil HA, Mathews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. British Medical Journal 321(7258):405-412.
Crossref

 

Tang TS, Brown MB, Funnell MM, Anderson RM (2008). Social support, quality of life, and self-care behaviors among African Americans with type 2 diabetes. Diabetes Education 34(2):266-276.
Crossref

 

Toobert DJ, Hampson SE, Glasgow RE (2000). The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care 23(7):943-950.
Crossref

 

Tuduri E, Soriano S, Almagro L, Montanya E, Alonso-Magdalena P, Nadal A, Quesada I (2022). The Pancreatic β-cell in ageing: Implications in age-related diabetes. Ageing Research Reviews 80:1-11.
Crossref

 

Unger T, Borghi C, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE (2020). International Society of Hypertension Global Hypertension Practice Guidelines. Hypertention 75:1334-1357.
Crossref

 

Valensi P, Husemoen LN, Weatherall J, Monnier L (2017). Association of postprandial and fasting plasma glucose with HbA1c across the spectrum of glycaemic impairment in type 2 diabetes. International Journal of Clinical Practice 71:e13041.
Crossref

 

Wang J, Li J, Wen C, Liu Y, Ma H (2021). Predictors of poor glycemic control among type 2 diabetes mellitus patients treated with antidiabetic medications: A cross-sectional study in China. Medicine (Baltimore):100:e2767.
Crossref

 

World Health Organization (WHO) (1999). Definition, diagnosis and classification of diabetes mellitus and its complications, Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus, WHO/NCD/NCS/99.2, Geneva.

 

Zheng Y, Ley SH, Hu FB (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Review in Endocrinology 14(2):88-98.
Crossref